Opportunity ID: 339680
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | W81XWH-22-PRARP-TRA |
Funding Opportunity Title: | DoD Peer Reviewed Alzheimer’s Research Program, Translational Research Award |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement Grant |
Category of Funding Activity: | Science and Technology and other Research and Development |
Category Explanation: | – |
Expected Number of Awards: | 2 |
Assistance Listings: | 12.420 — Military Medical Research and Development |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Apr 21, 2022 |
Last Updated Date: | Apr 21, 2022 |
Original Closing Date for Applications: | Jul 25, 2022 |
Current Closing Date for Applications: | Jul 25, 2022 |
Archive Date: | Aug 24, 2022 |
Estimated Total Program Funding: | $2,400,000 |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
Additional Information on Eligibility: | – |
Additional Information
Agency Name: | Dept. of the Army — USAMRAA |
Description: |
The intent of the FY22 PRARP TRA is to support translational research that will accelerate the movement of promising products and knowledge in AD/ADRD research into clinical applications, including healthcare products and interventions, technologies, behavioral modalities, social modalities, and/or clinical practice guidelines. This mechanism supports both preclinical-to-clinical translational research (e.g., studies of interventions and medical devices in preclinical systems) and clinical research-to-clinical care translation (e.g., comparative effectiveness, implementation science, healthcare services research). Observations that support a research idea may be derived from a laboratory discovery, population-based studies, or a clinician’s first-hand knowledge of patients and anecdotal data. Inclusion of preliminary data is required. Use of animal models, if applicable, must be fully justified for relevance to human health. Clinical research applications are required to include a community collaboration research element. Important aspects of this award mechanism include: Translational Potential: The PRARP does not view translational research as a one-way continuum from bench to bedside. The research plan is encouraged to involve a reciprocal flow of ideas and information between basic and clinical science or clinical and implementation science as appropriate. The application should detail steps to move the research along the research and development continuum. Relevance to Military Health: Projects must have relevance to military Service Members, Veterans, and/or their family members and care partners. Applicants are encouraged to integrate and/or align their research projects with Department of Defense (DOD) and/or Department of Veterans Affairs (VA) research laboratories and programs. Collaborations between researchers, at military or Veterans institutions and non-military institutions, are strongly encouraged. A list of websites that may be useful in identifying additional information about ongoing DOD and VA areas of research interest or potential opportunities for collaboration can be found in Appendix 2. |
Link to Additional Information: | – |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
CDMRP Help Desk
Phone: 301-682-5507 Email: help@eBRAP.org Email:help@eBRAP.org |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
Packages
Agency Contact Information: | CDMRP Help Desk Phone: 301-682-5507 Email: help@eBRAP.org Email: help@eBRAP.org |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
12.420 | PKG00273566 | Apr 21, 2022 | Jul 25, 2022 | View |